Doherty J. James's most recent trade in Acumen Pharmaceuticals Inc was a trade of 250,300 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acumen Pharma Inc | James J. Doherty | President and CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 250,300 | 250,300 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharma Inc | James J. Doherty | President and CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 166,867 | 220,900 | - | 0 | Common Stock | |
| Acumen Pharma Inc | James J. Doherty | President and CDO | Sale of securities on an exchange or to another person at price $ 1.82 per share. | 07 Jan 2026 | 6,467 | 54,033 | - | 1.8 | 11,769 | Common Stock |
| Acumen Pharma Inc | James J. Doherty | President and CDO | Sale of securities on an exchange or to another person at price $ 1.99 per share. | 07 Jan 2026 | 1,700 | 60,500 | - | 2.0 | 3,379 | Common Stock |
| Acumen Pharma Inc | James J. Doherty | President and CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 93,300 | 93,300 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharma Inc | James J. Doherty | President and CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 62,600 | 62,600 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Doherty J. James | President and CDO | 01 Feb 2024 | 601,000 | 601,000 | - | - | Employee Stock Option (right to buy) |